Townsquare Capital LLC Has $1.09 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Townsquare Capital LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,687 shares of the company’s stock after purchasing an additional 305 shares during the period. Townsquare Capital LLC’s holdings in HCA Healthcare were worth $1,092,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC boosted its holdings in HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after acquiring an additional 2,397,883 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in HCA Healthcare during the 2nd quarter valued at $131,527,000. Darsana Capital Partners LP lifted its stake in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares in the last quarter. Argent Capital Management LLC raised its holdings in shares of HCA Healthcare by 1,215.6% in the 2nd quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock worth $51,493,000 after acquiring an additional 148,092 shares during the last quarter. Finally, Epoch Investment Partners Inc. increased its holdings in HCA Healthcare by 16.4% during the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock worth $203,002,000 after purchasing an additional 88,948 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. TD Cowen dropped their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. KeyCorp cut their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $380.29.

Insider Transactions at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

NYSE:HCA opened at $327.62 on Tuesday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market cap of $82.99 billion, a price-to-earnings ratio of 14.71, a PEG ratio of 1.26 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $250.67 and a 52-week high of $417.14. The business’s fifty day moving average is $371.88 and its 200 day moving average is $358.84.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.